Intestinal Microbiome Post-Azythromycin/Albendazole Treatment

NCT03032042 · clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped We were not able to secure IRB approval in the timeline necessary to do this study.

Conditions

Interventions

Sponsor

University of California, San Francisco